NCT07184554 Lumbar Disc Hernia, Erector Spinae Plane Block, Ilesi
| NCT ID | NCT07184554 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Diskapi Teaching and Research Hospital |
| Condition | Lumbar Disc Herniation |
| Study Type | INTERVENTIONAL |
| Enrollment | 80 participants |
| Start Date | 2025-09-20 |
| Primary Completion | 2025-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 80 participants in total. It began in 2025-09-20 with a primary completion date of 2025-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study is designed as an observational study. Patients who have been treated and completed treatment for lumbar discopathy in our clinic will be followed. Patients will not be divided into groups beforehand, and this will not cause changes to the treatment plan. Patients who have undergone fluoroscopy-guided lumbar interlaminar epidural steroid injection (LESI) and ultrasound-guided lumbar erector spinae plane block (LESP), routinely performed in our clinic for the treatment of back and leg pain due to lumbar disc herniation, will be compared to the effectiveness of these methods on pain at baseline before the procedure and at 2, 6, and 12 weeks afterward using the Visual Analogue Scale for Pain Relief (VAS) and Oswestry Disability Index (ODI). The baseline values will be recorded from the patient files and by request before the start of follow-up.
Eligibility Criteria
Inclusion Criteria: * Patients with chronic low back pain caused by L4-L5 and L5-S1 lumbar disc herniation accompanied by radicular pain, including those diagnosed by MRI, will be included. * Patients with low back pain above VAS 5 for more than 6 weeks will be included. * Failure of pain treatment with conservative methods such as analgesics and physical therapy Exclusion Criteria: * Patients who have previously undergone lumbar surgery, * Patients with spinal deformity and stenosis, * Patients with uncontrolled diabetes * Patients allergic to the drugs to be used will not be included in the study. * Presence of psychiatric comorbidity * Local or systemic infection * Coagulopathy * Presence of rheumatological disease
Contact & Investigator
Gevher Rabia Genc Perdecioğlu
STUDY CHAIR
Diskapi TRH
Frequently Asked Questions
Who can join the NCT07184554 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Lumbar Disc Herniation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07184554 currently recruiting?
Yes, NCT07184554 is actively recruiting participants. Contact the research team at eminecan_02@hotmail.com for enrollment information.
Where is the NCT07184554 trial being conducted?
This trial is being conducted at Ankara, Turkey (Türkiye).
Who is sponsoring the NCT07184554 clinical trial?
NCT07184554 is sponsored by Diskapi Teaching and Research Hospital. The principal investigator is Gevher Rabia Genc Perdecioğlu at Diskapi TRH. The trial plans to enroll 80 participants.